MGF

MGF (Mechano Growth Factor) is a splice variant of IGF-1 that is produced locally in muscle tissue in response to mechanical stress — specifically, the eccentric loading and micro-damage that occurs during resistance training. The full name is IGF-1Ec (in humans), representing a unique C-terminal peptide sequence generated by alternative splicing of exon 5 and 6 of the IGF-1 gene. While systemic IGF-1 drives general anabolic signaling, MGF acts as a local, autocrine/paracrine signal that specifically activates muscle satellite cells — the resident stem cells responsible for muscle fiber repair and regeneration.

MGF's mechanism of action centers on satellite cell activation. Under normal conditions, satellite cells exist in a quiescent state beneath the basal lamina of muscle fibers. When muscle damage occurs, MGF is one of the first signals produced locally to activate these dormant cells, causing them to proliferate (expand the pool of repair cells) and subsequently differentiate into myonuclei that fuse with damaged fibers. MGF achieves this through IGF-1 receptor-independent signaling — its unique C-terminal E-domain peptide binds to receptors distinct from the classical IGF-1R, making its satellite cell activation complementary to rather than redundant with IGF-1 LR3. Researchers have documented that MGF's proliferative signal precedes the differentiation signal from mature IGF-1 splice variants, establishing it as the initial trigger in the muscle repair cascade.

The research literature documents MGF's effects on satellite cell proliferation, muscle repair acceleration, and local tissue regeneration. Studies using electrotransfer and direct injection models show significant increases in muscle fiber cross-sectional area and satellite cell marker expression. MGF has also shown effects in cardiac tissue repair, neuronal protection, and bone healing, suggesting its satellite cell activation mechanism is not muscle-exclusive.

MGF is suited for researchers investigating satellite cell biology, post-exercise muscle repair, local tissue regeneration, and the IGF-1 splice variant signaling hierarchy. It is commonly used in sequence with IGF-1 LR3: MGF administered immediately post-training for satellite cell activation, followed by IGF-1 LR3 to support the subsequent differentiation and maturation phase.

Reconstitute with 1-2ml bacteriostatic water. Administer via intramuscular injection directly into the target muscle group, ideally immediately post-training when local MGF production is naturally elevated. Standard MGF (non-PEGylated) has a very short half-life of approximately 5-7 minutes due to rapid enzymatic degradation, making timing and injection site critical. Typical research dosing is 100-200mcg per target muscle, administered bilaterally. Store at 2-8C after reconstitution. Due to the extremely short half-life, some researchers prefer the PEGylated version (PEG-MGF) for systemic protocols.